{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:46:45Z","timestamp":1790686005605,"version":"4.1.0"},"reference-count":116,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004160","name":"Mazandaran University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004160","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Comparative Immunology, Microbiology and Infectious Diseases"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.cimid.2020.101414","type":"journal-article","created":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T11:35:32Z","timestamp":1578396932000},"page":"101414","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"special_numbering":"C","title":["Toxoplasma gondii surface antigen 1 (SAG1) as a potential candidate to develop vaccine against toxoplasmosis: A systematic review"],"prefix":"10.1016","volume":"69","author":[{"given":"Abdol Sattar","family":"Pagheh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahabeddin","family":"Sarvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Sharif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Rezaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1202-6147","authenticated-orcid":false,"given":"Ehsan","family":"Ahmadpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samira","family":"Dodangeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Omidian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadi","family":"Hassannia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6619-2330","authenticated-orcid":false,"given":"Saeed","family":"Mehrzadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8571-5803","authenticated-orcid":false,"given":"Ahmad","family":"Daryani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.cimid.2020.101414_bib0005","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.exppara.2009.04.002","article-title":"Toxoplasma gondii: protective effect of an intranasal SAG1 and MIC4 DNA vaccine in mice","volume":"122","author":"Wang","year":"2009","journal-title":"Exp. Parasitol."},{"issue":"12","key":"10.1016\/j.cimid.2020.101414_bib0010","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.3855\/jidc.4796","article-title":"Toxoplasmosis in immunocompromised patients in Iran: a systematic review and meta-analysis","volume":"8","author":"Ahmadpour","year":"2014","journal-title":"J. Infect. Dev. Ctries."},{"issue":"3","key":"10.1016\/j.cimid.2020.101414_bib0015","doi-asserted-by":"crossref","first-page":"361","DOI":"10.3923\/jms.2007.361.367","article-title":"Enhancement of antibody immune response to a Toxoplasma gondii SAGl-encoded DNA vaccine by formulation with Aluminum Phosphate","volume":"7","author":"Solhjo","year":"2007","journal-title":"J. Med. Sci."},{"issue":"2","key":"10.1016\/j.cimid.2020.101414_bib0020","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/S1995-7645(14)60301-1","article-title":"Cattle toxoplasmosis in Iran: a systematic review and meta\u2013analysis","volume":"8","author":"Sarvi","year":"2015","journal-title":"Asian Pac. J. Trop. Med."},{"issue":"10","key":"10.1016\/j.cimid.2020.101414_bib0025","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1586\/erv.10.113","article-title":"Vaccination against Toxoplasma gondii: an increasing priority for collaborative research?","volume":"9","author":"Innes","year":"2010","journal-title":"Expert Rev. Vaccines"},{"issue":"9","key":"10.1016\/j.cimid.2020.101414_bib0030","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.4161\/hv.21006","article-title":"Vaccines against Toxoplasma gondii: status, challenges and future directions","volume":"8","author":"Liu","year":"2012","journal-title":"Hum. Vaccine Immunother."},{"issue":"2","key":"10.1016\/j.cimid.2020.101414_bib0035","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s00436-016-5325-6","article-title":"Immunological evaluation of a DNA cocktail vaccine with co-delivery of calcium phosphate nanoparticles (CaPNs) against the Toxoplasma gondii RH strain in BALB\/c mice","volume":"116","author":"Rahimi","year":"2017","journal-title":"Parasitol. Res."},{"issue":"5","key":"10.1016\/j.cimid.2020.101414_bib0040","doi-asserted-by":"crossref","first-page":"883","DOI":"10.4269\/ajtmh.12-0727","article-title":"Protective immune response in BALB\/c mice induced by DNA vaccine of the ROP8 gene of Toxoplasma gondii","volume":"88","author":"Parthasarathy","year":"2013","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"12","key":"10.1016\/j.cimid.2020.101414_bib0045","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/S0020-7519(01)00261-2","article-title":"Surface antigens of Toxoplasma gondii: variations on a theme","volume":"31","author":"Lekutis","year":"2001","journal-title":"Int. J. Parasitol."},{"issue":"4","key":"10.1016\/j.cimid.2020.101414_bib0050","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1089\/hum.2006.17.415","article-title":"Vaccination with replication-deficient recombinant adenoviruses encoding the main surface antigens of Toxoplasma gondii induces immune response and protection against infection in mice","volume":"17","author":"Caetano","year":"2006","journal-title":"Hum. Gene Ther."},{"issue":"1","key":"10.1016\/j.cimid.2020.101414_bib0055","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/1756-3305-7-180","article-title":"Research progress on surface antigen 1 (SAG1) of Toxoplasma gondii","volume":"7","author":"Wang","year":"2014","journal-title":"Parasit. Vectors"},{"issue":"7","key":"10.1016\/j.cimid.2020.101414_bib0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med."},{"key":"10.1016\/j.cimid.2020.101414_bib0065","unstructured":"Collaborative Approach to Meta-Analysis and Review of Animal Data from Experimental Studies. Available: [Accessed: 7-Aug -2017]; http:\/\/syrforguk\/protocols."},{"issue":"10","key":"10.1016\/j.cimid.2020.101414_bib0070","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.4049\/jimmunol.147.10.3501","article-title":"A purified parasite antigen (p30) mediates CD8+ T cell immunity against fatal Toxoplasma gondii infection in mice","volume":"147","author":"Khan","year":"1991","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.cimid.2020.101414_bib0075","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1365-3024.2008.01025.x","article-title":"Protective effect of a multiantigenic DNA vaccine against Toxoplasma gondii with co\u2010delivery of IL\u201012 in mice","volume":"30","author":"Cui","year":"2008","journal-title":"Parasite Immunol."},{"issue":"5","key":"10.1016\/j.cimid.2020.101414_bib0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0063201","article-title":"Recombinant vaccines against T. gondii: comparison between homologous and heterologous vaccination protocols using two viral vectors expressing SAG1","volume":"8","author":"Mendes","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.cimid.2020.101414_bib0085","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.exppara.2006.02.005","article-title":"Toxoplasma gondii: immunogenicity and protection by P30 peptides in a murine model","volume":"114","author":"Siachoque","year":"2006","journal-title":"Exp. Parasitol."},{"issue":"15","key":"10.1016\/j.cimid.2020.101414_bib0090","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S0161-5890(97)00133-8","article-title":"Differences in immunological response to a T. gondii protein (SAGI) derived peptide between two strains of mice: Effect on protection in T. gondii infection","volume":"34","author":"Velge-Roussel","year":"1997","journal-title":"Mol. Immunol."},{"issue":"1-2","key":"10.1016\/j.cimid.2020.101414_bib0095","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.vetpar.2011.12.007","article-title":"Evaluation of immune responses induced by SAG1 and MIC3 vaccine cocktails against Toxoplasma gondii","volume":"187","author":"Fang","year":"2012","journal-title":"Vet. Parasitol."},{"issue":"1","key":"10.1016\/j.cimid.2020.101414_sbref0100a","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.exppara.2012.02.026","article-title":"Toxoplasma gondii: the vaccine potential of three trivalent antigen-cocktails composed of recombinant ROP2, ROP4, GRA4 and SAG1 proteins against chronic toxoplasmosis in BALB\/c mice","volume":"131","author":"Dziadek","year":"2012","journal-title":"Exp. Parasitol."},{"issue":"6","key":"10.1016\/j.cimid.2020.101414_sbref0100b","doi-asserted-by":"crossref","first-page":"358","DOI":"10.4161\/bioe.21541","article-title":"Recombinant ROP2, ROP4, GRA4 and SAG1 antigen-cocktails as possible tools for immunoprophylaxis of toxoplasmosis: what\u2019s next?","volume":"3","author":"Dziadek","year":"2012","journal-title":"Bioengineered"},{"issue":"1","key":"10.1016\/j.cimid.2020.101414_bib0105","first-page":"1","article-title":"Toxoplasma gondii recombinant surface antigen (SAG 1; P 30) and its applications in serodiagnosis and vaccine development for toxoplasmosis","volume":"6","author":"Abdullah","year":"2010","journal-title":"Malays. J. Med. Health. Sci."},{"issue":"5","key":"10.1016\/j.cimid.2020.101414_bib0110","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.4049\/jimmunol.164.5.2629","article-title":"Decreased resistance of B cell-deficient mice to infection with Toxoplasma gondii despite unimpaired expression of IFN-\u03b3, TNF-\u03b1, and inducible nitric oxide synthase","volume":"164","author":"Kang","year":"2000","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.cimid.2020.101414_bib0115","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1638\/03-060","article-title":"Preliminary results of an anticircumsporozoite DNA vaccine trial for protection against avian malaria in captive African black-footed penguins (Spheniscus demersus)","volume":"35","author":"Grim","year":"2004","journal-title":"J. Zoo Wildl. Med."},{"issue":"1","key":"10.1016\/j.cimid.2020.101414_bib0120","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.rvsc.2010.01.007","article-title":"The protective effect of a Toxoplasma gondii SAG1 plasmid DNA vaccine in mice is enhanced with IL-18","volume":"89","author":"Liu","year":"2010","journal-title":"Res. Vet. Sci."},{"issue":"12","key":"10.1016\/j.cimid.2020.101414_bib0125","doi-asserted-by":"crossref","first-page":"6358","DOI":"10.1128\/IAI.67.12.6358-6363.1999","article-title":"Complete protection against lethal Toxoplasma gondii infection in mice immunized with a plasmid encoding the SAG1 gene","volume":"67","author":"Nielsen","year":"1999","journal-title":"Infect. Immun."},{"issue":"21-22","key":"10.1016\/j.cimid.2020.101414_bib0130","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1016\/S0264-410X(03)00163-4","article-title":"DNA vaccination with the immunodominant tachyzoite surface antigen (SAG-1) protects against adult acquired Toxoplasma gondii infection but does not prevent maternofoetal transmission","volume":"21","author":"Couper","year":"2003","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.cimid.2020.101414_bib0135","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s00436-011-2296-5","article-title":"Comparative evaluation of immunization with recombinant protein and plasmid DNA vaccines of fusion antigen ROP2 and SAG1 from Toxoplasma gondii in mice: cellular and humoral immune responses","volume":"109","author":"Li","year":"2011","journal-title":"Parasitol. Res."},{"issue":"2","key":"10.1016\/j.cimid.2020.101414_bib0140","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1590\/S0074-02762009000200019","article-title":"Vaccines against Toxoplasma gondii: challenges and opportunities","volume":"104","author":"Jongert","year":"2009","journal-title":"Mem. Inst. Oswaldo Cruz"},{"issue":"31","key":"10.1016\/j.cimid.2020.101414_bib0145","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1016\/j.vaccine.2008.04.046","article-title":"Multi-epitope DNA vaccine linked to the A2\/B subunit of cholera toxin protect mice against Toxoplasma gondii","volume":"26","author":"Cong","year":"2008","journal-title":"Vaccine"},{"issue":"48","key":"10.1016\/j.cimid.2020.101414_bib0150","doi-asserted-by":"crossref","first-page":"6757","DOI":"10.1016\/j.vaccine.2015.10.077","article-title":"Toxoplasma gondii: vaccination with a DNA vaccine encoding T-and B-cell epitopes of SAG1, GRA2, GRA7 and ROP16 elicits protection against acute toxoplasmosis in mice","volume":"33","author":"Cao","year":"2015","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.cimid.2020.101414_bib0155","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/0952-7915(94)90143-0","article-title":"Recombinant vaccine delivery systems and encoded vaccines","volume":"6","author":"Stover","year":"1994","journal-title":"Curr. Opin. Immunol."},{"issue":"18","key":"10.1016\/j.cimid.2020.101414_bib0160","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.1016\/j.vaccine.2010.02.003","article-title":"Prime and boost immunization with influenza and adenovirus encoding the Toxoplasma gondii surface antigen 2 (SAG2) induces strong protective immunity","volume":"28","author":"Machado","year":"2010","journal-title":"Vaccine"},{"issue":"3-4","key":"10.1016\/j.cimid.2020.101414_bib0165","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.vetpar.2009.08.016","article-title":"Induction of protective immunity by multiantigenic DNA vaccine delivered in attenuated Salmonella typhimurium against Toxoplasma gondii infection in mice","volume":"166","author":"Qu","year":"2009","journal-title":"Vet. Parasitol."},{"issue":"2-4","key":"10.1016\/j.cimid.2020.101414_bib0170","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.vetpar.2011.04.039","article-title":"Immunogenicity and protective efficacy of two recombinant pseudorabies viruses expressing Toxoplasma gondii SAG1 and MIC3 proteins","volume":"181","author":"Nie","year":"2011","journal-title":"Vet. Parasitol."},{"issue":"7","key":"10.1016\/j.cimid.2020.101414_bib0175","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1348-0421.2005.tb03656.x","article-title":"Protective effect of vaccination with Toxoplasma lysate antigen and CpG as an adjuvant against Toxoplasma gondii in susceptible C57BL\/6 mice","volume":"49","author":"El\u2010Malky","year":"2005","journal-title":"Microbiol. Immunol."},{"issue":"1","key":"10.1016\/j.cimid.2020.101414_bib0180","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1756-3305-6-63","article-title":"Compound DNA vaccine encoding SAG1\/SAG3 with A 2\/B subunit of cholera toxin as a genetic adjuvant protects BALB\/c mice against Toxoplasma gondii","volume":"6","author":"Cong","year":"2013","journal-title":"Parasit. Vectors"},{"issue":"2","key":"10.1016\/j.cimid.2020.101414_bib0185","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00436-007-0465-3","article-title":"Evaluation of the immune response induced by multiantigenic DNA vaccine encoding SAG1 and ROP2 of Toxoplasma gondii and the adjuvant properties of murine interleukin-12 plasmid in BALB\/c mice","volume":"101","author":"Zhang","year":"2007","journal-title":"Parasitol. Res."},{"issue":"9","key":"10.1016\/j.cimid.2020.101414_bib0190","doi-asserted-by":"crossref","first-page":"4503","DOI":"10.1128\/IAI.66.9.4503-4506.1998","article-title":"Protective effect of vaccination with a combination of recombinant surface antigen 1 and interleukin-12 against toxoplasmosis in mice","volume":"66","author":"Letscher-Bru","year":"1998","journal-title":"Infect. Immun."},{"issue":"4","key":"10.1016\/j.cimid.2020.101414_bib0195","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.exppara.2013.04.002","article-title":"Encapsulation of chimeric protein rSAG1\/2 into poly (lactide-co-glycolide) microparticles induces long-term protective immunity against Toxoplasma gondii in mice","volume":"134","author":"Chuang","year":"2013","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.cimid.2020.101414_bib0200","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.imlet.2017.03.006","article-title":"Enhancing immune responses to a DNA vaccine encoding Toxoplasma gondii GRA14 by calcium phosphate nanoparticles as an adjuvant","volume":"185","author":"Ahmadpour","year":"2017","journal-title":"Immunol. Lett."},{"issue":"6","key":"10.1016\/j.cimid.2020.101414_bib0205","first-page":"420","article-title":"Inbred and outbred mice have equivalent variability in a cockroach allergen-induced model of asthma","volume":"60","author":"Vaickus","year":"2010","journal-title":"Comp. Med."},{"issue":"1","key":"10.1016\/j.cimid.2020.101414_bib0210","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1017\/S0031182000060753","article-title":"Studies on a murine model of congenital toxoplasmosis: vertical disease transmission only occurs in BALB\/c mice infected for the first time during pregnancy","volume":"104","author":"Roberts","year":"1992","journal-title":"Parasitology"},{"issue":"6","key":"10.1016\/j.cimid.2020.101414_bib0215","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1128\/iai.64.6.2158-2166.1996","article-title":"Intranasal immunization with SAG1 protein of Toxoplasma gondii in association with cholera toxin dramatically reduces development of cerebral cysts after oral infection","volume":"64","author":"Debard","year":"1996","journal-title":"Infect. Immun."},{"issue":"3","key":"10.1016\/j.cimid.2020.101414_bib0220","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1128\/iai.65.3.1119-1121.1997","article-title":"Innate immunity to Toxoplasma gondii is influenced by gender and is associated with differences in interleukin-12 and gamma interferon production","volume":"65","author":"Walker","year":"1997","journal-title":"Infect. Immun."},{"issue":"2","key":"10.1016\/j.cimid.2020.101414_bib0225","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1586\/14760584.8.2.215","article-title":"Vaccination concepts against Toxoplasma gondii","volume":"8","author":"Garcia","year":"2009","journal-title":"Expert Rev. Vaccines"},{"issue":"2","key":"10.1016\/j.cimid.2020.101414_bib0230","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1128\/IAI.68.2.969-972.2000","article-title":"Intranasal immunization with Toxoplasma gondii SAG1 induces protective cells into both NALT and GALT compartments","volume":"68","author":"Velge-Roussel","year":"2000","journal-title":"Infect. Immun."},{"issue":"9","key":"10.1016\/j.cimid.2020.101414_bib0235","doi-asserted-by":"crossref","first-page":"4948","DOI":"10.1128\/IAI.68.9.4948-4953.2000","article-title":"Protective immunity against congenital toxoplasmosis with recombinant SAG1 protein in a guinea pig model","volume":"68","author":"Haumont","year":"2000","journal-title":"Infect. Immun."},{"issue":"9\u201310","key":"10.1016\/j.cimid.2020.101414_bib0240","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/j.1365-3024.2010.01228.x","article-title":"Immunological response of sheep to injections of plasmids encoding Toxoplasma gondii SAG1 and ROP1 genes","volume":"32","author":"Li","year":"2010","journal-title":"Parasite Immunol."},{"issue":"5","key":"10.1016\/j.cimid.2020.101414_bib0245","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1136\/vr.129.5.89","article-title":"Vaccination of sheep with a live incomplete strain (S48) of Toxoplasma gondii and their immunity to challenge when pregnant","volume":"129","author":"Buxton","year":"1991","journal-title":"Vet. Rec."},{"issue":"6","key":"10.1016\/j.cimid.2020.101414_bib0250","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1093\/infdis\/172.6.1561","article-title":"Toxoplasma gondii comprises three clonal lineages: correlation of parasite genotype with human disease","volume":"172","author":"Howe","year":"1995","journal-title":"J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.cimid.2020.101414_bib0255","article-title":"Genotypes and mouse virulence of Toxoplasma gondii isolates from animals and humans in China","volume":"8","author":"Wang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.cimid.2020.101414_bib0260","first-page":"923","article-title":"The optimal choice of medication administration route regarding intravenous, intramuscular, and subcutaneous injection","volume":"9","author":"Jin","year":"2015","journal-title":"Patient Prefer. Adherence"},{"issue":"3","key":"10.1016\/j.cimid.2020.101414_bib0265","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1128\/IAI.69.3.1605-1612.2001","article-title":"Intranasal immunization with SAG1 and nontoxic mutant heat-labile enterotoxins protects mice against toxoplasma gondii","volume":"69","author":"Bonenfant","year":"2001","journal-title":"Infect. Immun."},{"issue":"3","key":"10.1016\/j.cimid.2020.101414_bib0270","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1007\/s00436-011-2315-6","article-title":"Immunogenic characterization of the chimeric surface antigen 1 and 2 (SAG1\/2) of Toxoplasma gondii expressed in the yeast Pichia pastoris","volume":"109","author":"Lau","year":"2011","journal-title":"Parasitol. Res."},{"issue":"4","key":"10.1016\/j.cimid.2020.101414_bib0275","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1128\/CMR.11.4.569","article-title":"Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection","volume":"11","author":"Denkers","year":"1998","journal-title":"Clin. Microbiol. Rev."},{"issue":"4","key":"10.1016\/j.cimid.2020.101414_bib0280","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.4049\/jimmunol.0901843","article-title":"IL-6 promotes NK cell production of IL-17 during toxoplasmosis","volume":"184","author":"Passos","year":"2010","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.cimid.2020.101414_bib0285","first-page":"71","article-title":"Immune response to Toxoplasma gondii","volume":"40","author":"Filisetti","year":"2004","journal-title":"Ann. Ist. Super. Sanita"},{"issue":"10","key":"10.1016\/j.cimid.2020.101414_bib0290","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1016\/j.vaccine.2012.01.004","article-title":"Protective immune response against Toxoplasma gondii elicited by a recombinant DNA vaccine with a novel genetic adjuvant","volume":"30","author":"Zhou","year":"2012","journal-title":"Vaccine"},{"issue":"1-3","key":"10.1016\/j.cimid.2020.101414_bib0295","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.vetpar.2011.02.008","article-title":"Ginsenoside Rg1 enhances immune response induced by recombinant Toxoplasma gondii SAG1 antigen","volume":"179","author":"Qu","year":"2011","journal-title":"Vet. Parasitol."},{"issue":"5","key":"10.1016\/j.cimid.2020.101414_bib0300","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.4049\/jimmunol.134.5.3426","article-title":"An unexpected response to vaccination with a purified major membrane tachyzoite antigen (P30) of Toxoplasma gondii","volume":"134","author":"Kasper","year":"1985","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.cimid.2020.101414_bib0305","doi-asserted-by":"crossref","first-page":"3496","DOI":"10.4049\/jimmunol.147.10.3496","article-title":"Protection of mice from fatal Toxoplasma gondii infection by immunization with p30 antigen in liposomes","volume":"147","author":"B\u00fclow","year":"1991","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.cimid.2020.101414_bib0310","doi-asserted-by":"crossref","first-page":"3636","DOI":"10.4049\/jimmunol.149.11.3636","article-title":"Protection of mice and nude rats against toxoplasmosis by a multiple antigenic peptide construction derived from Toxoplasma gondii P30 antigen","volume":"149","author":"Darcy","year":"1992","journal-title":"J. Immunol."},{"issue":"13","key":"10.1016\/j.cimid.2020.101414_bib0315","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/S0264-410X(98)00039-5","article-title":"Immunization with E. coli produced recombinant T. gondii SAG1 with alum as adjuvant protect mice against lethal infection with Toxoplasma gondii","volume":"16","author":"Petersen","year":"1998","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.cimid.2020.101414_bib0320","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1348-0421.1999.tb02378.x","article-title":"Protective immunity induced by vaccination with SAG1 gene-transfected cells against Toxoplasma gondii-infection in mice","volume":"43","author":"Aosai","year":"1999","journal-title":"Microbiol. Immunol."},{"issue":"15-16","key":"10.1016\/j.cimid.2020.101414_bib0325","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1016\/S0264-410X(98)00463-0","article-title":"Salbutamol as an adjuvant for nasal vaccination","volume":"17","author":"Fermin","year":"1999","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.cimid.2020.101414_bib0330","doi-asserted-by":"crossref","first-page":"6615","DOI":"10.1128\/IAI.71.11.6615-6619.2003","article-title":"Vaccination with Toxoplasma gondii SAG-1 protein is protective against congenital toxoplasmosis in BALB\/c mice but not in CBA\/J mice","volume":"71","author":"Letscher-Bru","year":"2003","journal-title":"Infect. Immun."},{"issue":"6","key":"10.1016\/j.cimid.2020.101414_bib0335","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s00436-005-0074-y","article-title":"Effect of rSAG-1 (P30) immunisation on the circulating and tissue parasites in guinea pigs as determined by quantitative PCR","volume":"98","author":"Flori","year":"2006","journal-title":"Parasitol. Res."},{"issue":"1","key":"10.1016\/j.cimid.2020.101414_bib0340","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00436-009-1393-1","article-title":"Evaluation of protective effect of multi-epitope DNA vaccine encoding six antigen segments of Toxoplasma gondii in mice","volume":"105","author":"Liu","year":"2009","journal-title":"Parasitol. Res."},{"issue":"1","key":"10.1016\/j.cimid.2020.101414_bib0345","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1756-3305-6-34","article-title":"Induction of long-lasting protective immunity against Toxoplasma gondii in BALB\/c mice by recombinant surface antigen 1 protein encapsulated in poly (lactide-co-glycolide) microparticles","volume":"6","author":"Chuang","year":"2013","journal-title":"Parasit. Vectors"},{"issue":"5","key":"10.1016\/j.cimid.2020.101414_bib0350","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/biot.201400742","article-title":"The fusion of Toxoplasma gondii SAG1 vaccine candidate to Leishmania infantum heat shock protein 83\u2010kDa improves expression levels in tobacco chloroplasts","volume":"10","author":"Albarrac\u00edn","year":"2015","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.cimid.2020.101414_bib0355","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3389\/fimmu.2018.00317","article-title":"Targeted Delivery of Toxoplasma gondii antigens to Dendritic cells promote immunogenicity and Protective efficiency against Toxoplasmosis","volume":"9","author":"Lakhrif","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cimid.2020.101414_bib0360","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1080\/21691401.2018.1478421","article-title":"Induction of Th1 type-oriented humoral response through intranasal immunization of mice with SAG1-Toxoplasma gondii polymeric nanospheres","volume":"46","author":"Naeem","year":"2018","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"issue":"6","key":"10.1016\/j.cimid.2020.101414_bib0365","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1128\/iai.61.6.2639-2643.1993","article-title":"Immune responses and resistance to Toxoplasma gondii in mice immunized with antigens of the parasite incorporated into immunostimulating complexes","volume":"61","author":"Lund\u00e9n","year":"1993","journal-title":"Infect. Immun."},{"issue":"1","key":"10.1016\/j.cimid.2020.101414_bib0370","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s00436-003-0992-5","article-title":"Protective immunity against Toxoplasma gondii in mice induced by a chimeric protein rSAG1\/2","volume":"92","author":"Yang","year":"2004","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.cimid.2020.101414_bib0375","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1051\/parasite\/2017004","article-title":"Protective immunity against toxoplasmosis in mice induced by single-dose immunization with rSAG1\/2 protein released from poly (lactide-co-glycolide) microparticles","volume":"24","author":"Chuang","year":"2017","journal-title":"Parasite"},{"key":"10.1016\/j.cimid.2020.101414_bib0380","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.exppara.2016.09.008","article-title":"Synergistic effect of rSAG1 and rGRA2 antigens formulated in PLGA microspheres in eliciting immune protection against Toxoplasama gondii","volume":"170","author":"Allahyari","year":"2016","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.cimid.2020.101414_bib0385","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.smallrumres.2017.03.008","article-title":"Toxoplasma gondii: immunological response of sheep to injections of recombinant SAG1, SAG2, GRA1 proteins coupled to the non-toxic microparticle muramyl dipeptide","volume":"150","author":"Oledzka","year":"2017","journal-title":"Small Rumin. Res."},{"issue":"47","key":"10.1016\/j.cimid.2020.101414_bib0390","doi-asserted-by":"crossref","first-page":"8619","DOI":"10.1016\/j.vaccine.2011.09.016","article-title":"Increased survival time in mice vaccinated with a branched lysine multiple antigenic peptide containing B-and T-cell epitopes from T. gondii antigens","volume":"29","author":"Wang","year":"2011","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.cimid.2020.101414_bib0395","first-page":"215","article-title":"Immunogenicity of multiepitope vaccine candidate against toxoplasma gondii infection in BALB\/c mice","volume":"13","author":"Hajissa","year":"2018","journal-title":"Iran. J. Parasitol."},{"issue":"1","key":"10.1016\/j.cimid.2020.101414_bib0400","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1745-7580-6-12","volume":"6","author":"Cong","year":"2010","journal-title":"Immunome Res."},{"issue":"5","key":"10.1016\/j.cimid.2020.101414_bib0405","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0126334","article-title":"Prime-boost vaccination with Toxoplasma lysate antigen, but not with a mixture of recombinant protein antigens, leads to reduction of brain cyst formation in BALB\/c mice","volume":"10","author":"Wagner","year":"2015","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.cimid.2020.101414_bib0410","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.vaccine.2010.11.002","article-title":"Evaluation of three recombinant multi-antigenic vaccines composed of surface and secretory antigens of Toxoplasma gondii in murine models of experimental toxoplasmosis","volume":"29","author":"Dziadek","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.cimid.2020.101414_bib0415","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.vetpar.2018.02.043","article-title":"Assessment of the antigenic and neuroprotective activity of the subunit anti-Toxoplasma vaccine in T. gondii experimentally infected mice","volume":"254","author":"Gatkowska","year":"2018","journal-title":"Vet. Parasitol."},{"issue":"41","key":"10.1016\/j.cimid.2020.101414_bib0420","doi-asserted-by":"crossref","first-page":"6124","DOI":"10.1016\/j.vaccine.2018.08.068","article-title":"M.J. Gharavi. Characterization of a multi-epitope peptide with selective MHC-binding capabilities encapsulated in PLGA nanoparticles as a novel vaccine candidate against Toxoplasma gondii infection","volume":"36","author":"Roozbehani","year":"2018","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.cimid.2020.101414_bib0425","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1292\/jvms.63.433","article-title":"Modified protection against Toxoplasma gondii lethal infection and brain cyst formation by vaccination with SAG2 and SRS1","volume":"63","author":"Mishima","year":"2001","journal-title":"J. Vet. Med. Sci."},{"issue":"41","key":"10.1016\/j.cimid.2020.101414_bib0430","doi-asserted-by":"crossref","first-page":"5289","DOI":"10.1016\/j.vaccine.2008.07.032","article-title":"Protective Th1 immune responses against chronic toxoplasmosis induced by a protein\u2013protein vaccine combination but not by its DNA\u2013protein counterpart","volume":"26","author":"Jongert","year":"2008","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.cimid.2020.101414_bib0435","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1086\/315186","article-title":"Immunization with a DNA plasmid encoding the SAG1 (P30) protein of Toxoplasma gondii is immunogenic and protective in rodents","volume":"181","author":"Angus","year":"2000","journal-title":"J. Infect. Dis."},{"issue":"10","key":"10.1016\/j.cimid.2020.101414_bib0440","first-page":"1448","article-title":"Protective effect of DNA-mediated immunization with a combination of SAG1 and IL-2 gene adjuvant against infection of Toxoplasma gondii in mice","volume":"115","author":"Chen","year":"2002","journal-title":"Chin. Med. J."},{"issue":"15-16","key":"10.1016\/j.cimid.2020.101414_bib0445","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1016\/S0264-410X(00)00366-2","article-title":"Establishment of gene-vaccinated skin grafting against Toxoplasma gondii infection in mice","volume":"19","author":"Saito","year":"2001","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.cimid.2020.101414_bib0450","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1472-6750-10-52","article-title":"Effect of codon optimization and subcellular targeting on Toxoplasma gondii antigen SAG1 expression in tobacco leaves to use in subcutaneous and oral immunization in mice","volume":"10","author":"Lagu\u00eda-Becher","year":"2010","journal-title":"BMC Biotechnol."},{"issue":"5","key":"10.1016\/j.cimid.2020.101414_bib0455","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1007\/s00436-012-3047-y","article-title":"Multicomponent DNA vaccine-encoding Toxoplasma gondii GRA1 and SAG1 primes: anti-Toxoplasma immune response in mice","volume":"111","author":"Wu","year":"2012","journal-title":"Parasitol. Res."},{"issue":"36","key":"10.1016\/j.cimid.2020.101414_bib0460","doi-asserted-by":"crossref","first-page":"4489","DOI":"10.1016\/j.vaccine.2005.04.025","article-title":"Evaluation of protective effect of DNA vaccination with genes encoding antigens GRA4 and SAG1 associated with GM-CSF plasmid, against acute, chronical and congenital toxoplasmosis in mice","volume":"23","author":"M\u00e9v\u00e9lec","year":"2005","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.cimid.2020.101414_bib0465","first-page":"81","article-title":"Protective immunity induced in mice by multiantigenic DNA vaccine with genes encoding SAG1 and MIC8 of Toxoplasma gondii","volume":"28","author":"Yao","year":"2010","journal-title":"Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi"},{"issue":"10","key":"10.1016\/j.cimid.2020.101414_bib0470","first-page":"1561","article-title":"Induction of immune responses in mice by vaccination with Liposome-entrapped DNA complexes encoding Toxoplasma gondii SAG1 and ROP1 genes","volume":"116","author":"Chen","year":"2003","journal-title":"Chin. Med. J."},{"issue":"13-14","key":"10.1016\/j.cimid.2020.101414_bib0475","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/S0264-410X(02)00692-8","article-title":"Protective effect of a naked DNA vaccine cocktail against lethal toxoplasmosis in mice","volume":"21","author":"Fachado","year":"2003","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.cimid.2020.101414_bib0480","first-page":"14","article-title":"Construction of monovalent and compound nucleic acid vaccines against Toxoplasma gondii with gene encoding p30","volume":"23","author":"Yang","year":"2005","journal-title":"Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi"},{"issue":"3","key":"10.1016\/j.cimid.2020.101414_bib0485","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.exppara.2008.03.005","article-title":"Comparison of cholera toxin A2\/B and murine interleukin-12 as adjuvants of Toxoplasma multi-antigenic SAG1-ROP2 DNA vaccine","volume":"119","author":"Xue","year":"2008","journal-title":"Exp. Parasitol."},{"issue":"4","key":"10.1016\/j.cimid.2020.101414_bib0490","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.vaccine.2010.11.012","article-title":"Evaluation of the immune response induced by DNA vaccine cocktail expressing complete SAG1 and ROP2 genes against toxoplasmosis","volume":"29","author":"Khosroshahi","year":"2011","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.cimid.2020.101414_bib0495","first-page":"1","article-title":"Immune response in mice induced by complex gene vaccine pcSAG1-ROP5 of Toxoplasma gondii","volume":"31","author":"Zhao","year":"2013","journal-title":"Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi"},{"issue":"1","key":"10.1016\/j.cimid.2020.101414_bib0500","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1186\/1756-3305-5-273","article-title":"Evaluation of protective immune responses induced by DNA vaccines encoding Toxoplasma gondii surface antigen 1 (SAG1) and 14-3-3 protein in BALB\/c mice","volume":"5","author":"Meng","year":"2012","journal-title":"Parasit. Vectors"},{"issue":"4","key":"10.1016\/j.cimid.2020.101414_bib0505","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.parint.2008.05.001","article-title":"Evaluation of the immune response elicited by multi-antigenic DNA vaccine expressing SAG1, ROP2 and GRA2 against Toxoplasma gondii","volume":"57","author":"Xue","year":"2008","journal-title":"Parasitol. Int."},{"issue":"4","key":"10.1016\/j.cimid.2020.101414_bib0510","first-page":"590","article-title":"Evaluation of immunogenicity of cocktail DNA vaccine containing plasmids encoding complete GRA5, SAG1, and ROP2 antigens of Toxoplasma gondii in BALB\/C mice","volume":"10","author":"Naserifar","year":"2015","journal-title":"Iran. J. Parasitol."},{"issue":"21-22","key":"10.1016\/j.cimid.2020.101414_bib0515","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1016\/S0264-410X(03)00157-9","article-title":"Induction of protective immunity by DNA vaccination with Toxoplasma gondii HSP70, HSP30 and SAG1 genes","volume":"21","author":"Mohamed","year":"2003","journal-title":"Vaccine"},{"issue":"18","key":"10.1016\/j.cimid.2020.101414_bib0520","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1016\/j.vaccine.2009.02.058","article-title":"Induction of partial protection against infection with Toxoplasma gondii genotype II by DNA vaccination with recombinant chimeric tachyzoite antigens","volume":"27","author":"Rosenberg","year":"2009","journal-title":"Vaccine"},{"issue":"12\u201313","key":"10.1016\/j.cimid.2020.101414_bib0525","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.micinf.2008.08.002","article-title":"A recombinant pseudorabies virus expressing TgSAG1 protects against challenge with the virulent Toxoplasma gondii RH strain and pseudorabies in BALB\/c mice","volume":"10","author":"Liu","year":"2008","journal-title":"Microbes Infect."},{"issue":"35","key":"10.1016\/j.cimid.2020.101414_bib0530","doi-asserted-by":"crossref","first-page":"4541","DOI":"10.1016\/j.vaccine.2008.06.030","article-title":"Protective effect of a DNA vaccine delivered in attenuated Salmonella typhimurium against Toxoplasma gondii infection in mice","volume":"26","author":"Qu","year":"2008","journal-title":"Vaccine"},{"issue":"21","key":"10.1016\/j.cimid.2020.101414_bib0535","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1016\/j.vaccine.2009.03.013","article-title":"Protection in mice immunized with a heterologous prime-boost regime using DNA and recombinant pseudorabies expressing TgSAG1 against Toxoplasma gondii challenge","volume":"27","author":"Shang","year":"2009","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.cimid.2020.101414_bib0540","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/j.vaccine.2009.12.005","article-title":"Construction and immunogenicity of pseudotype baculovirus expressing Toxoplasma gondii SAG1 protein in BALB\/c mice model","volume":"28","author":"Fang","year":"2010","journal-title":"Vaccine"},{"issue":"45","key":"10.1016\/j.cimid.2020.101414_bib0545","doi-asserted-by":"crossref","first-page":"7243","DOI":"10.1016\/j.vaccine.2010.08.096","article-title":"Construction of Neospora caninum stably expressing TgSAG1 and evaluation of its protective effects against Toxoplasma gondii infection in mice","volume":"28","author":"Zhang","year":"2010","journal-title":"Vaccine"},{"issue":"1\u20102","key":"10.1016\/j.cimid.2020.101414_bib0550","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1365-3024.2005.00738.x","article-title":"Oral immunization with a live recombinant attenuated Salmonella typhimurium protects mice against Toxoplasma gondii","volume":"27","author":"Cong","year":"2005","journal-title":"Parasite Immunol."},{"issue":"2","key":"10.1016\/j.cimid.2020.101414_bib0555","first-page":"115","article-title":"Effect of Escherichia coli heat-labile enterotoxin B subunit on SAG1-ROP2 compound gene vaccine of Toxoplasma gondii tachyzoite","volume":"28","author":"Zhao","year":"2010","journal-title":"Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi"},{"issue":"7","key":"10.1016\/j.cimid.2020.101414_bib0560","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1089\/vim.2016.0135","article-title":"Major immunodominant region of hepatitis B virus core antigen as a delivery vector to improve the immunogenicity of the fusion antigen ROP2-SAG1 multiepitope from toxoplasma gondii in mice","volume":"30","author":"Wang","year":"2017","journal-title":"Viral Immunol."},{"issue":"27","key":"10.1016\/j.cimid.2020.101414_bib0565","doi-asserted-by":"crossref","first-page":"4476","DOI":"10.1016\/j.vaccine.2011.04.044","article-title":"MyD88-dependent protective immunity elicited by adenovirus 5 expressing the surface antigen 1 from Toxoplasma gondii is mediated by CD8+ T lymphocytes","volume":"29","author":"Mendes","year":"2011","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.cimid.2020.101414_bib0570","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.exppara.2007.07.003","article-title":"Toxoplasma gondii: chimeric Dr fimbriae as a recombinant vaccine against toxoplasmosis","volume":"118","author":"Gatkowska","year":"2008","journal-title":"Exp. Parasitol."},{"issue":"1","key":"10.1016\/j.cimid.2020.101414_bib0575","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/1756-3305-7-145","article-title":"Comparative efficacy of a multi-epitope DNA vaccine via intranasal, peroral, and intramuscular delivery against lethal Toxoplasma gondii infection in mice","volume":"7","author":"Cong","year":"2014","journal-title":"Parasit. Vectors"}],"container-title":["Comparative Immunology, Microbiology and Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0147957120300023?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0147957120300023?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T06:44:24Z","timestamp":1758955464000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0147957120300023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":116,"alternative-id":["S0147957120300023"],"URL":"https:\/\/doi.org\/10.1016\/j.cimid.2020.101414","relation":{},"ISSN":["0147-9571"],"issn-type":[{"value":"0147-9571","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Toxoplasma gondii surface antigen 1 (SAG1) as a potential candidate to develop vaccine against toxoplasmosis: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Comparative Immunology, Microbiology and Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cimid.2020.101414","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101414"}}